Policy Reversal: FDA Will No Longer Require Suffixes for Older Biologics
March 7, 2019
Michael Cipriano
Pink Sheet
Axinn partner Chad Landmon was quoted in the Pink Sheet article, "Policy Reversal: FDA Will No Longer Require Suffixes for Older Biologics."
Click here to access the article.